- Home
- HLF vs KURA Comparison
HLF vs KURA Comparison
Compare HLF & KURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HLF
- KURA
- Stock Information
- Founded
- HLF 1980
- KURA 2014
- Country
- HLF United States
- KURA United States
- Employees
- HLF N/A
- KURA N/A
- Industry
- HLF Other Pharmaceuticals
- KURA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HLF Health Care
- KURA Health Care
- Exchange
- HLF Nasdaq
- KURA Nasdaq
- Market Cap
- HLF 583.2M
- KURA 592.7M
- IPO Year
- HLF N/A
- KURA N/A
- Fundamental
- Price
- HLF $8.83
- KURA $6.52
- Analyst Decision
- HLF Strong Buy
- KURA Strong Buy
- Analyst Count
- HLF 4
- KURA 10
- Target Price
- HLF $12.00
- KURA $25.50
- AVG Volume (30 Days)
- HLF 1.8M
- KURA 1.1M
- Earning Date
- HLF 04-30-2025
- KURA 05-01-2025
- Dividend Yield
- HLF N/A
- KURA N/A
- EPS Growth
- HLF 76.06
- KURA N/A
- EPS
- HLF 2.50
- KURA N/A
- Revenue
- HLF $4,993,100,000.00
- KURA $53,883,000.00
- Revenue This Year
- HLF $0.44
- KURA $13.15
- Revenue Next Year
- HLF $3.71
- KURA $221.86
- P/E Ratio
- HLF $3.52
- KURA N/A
- Revenue Growth
- HLF N/A
- KURA N/A
- 52 Week Low
- HLF $5.04
- KURA $6.27
- 52 Week High
- HLF $12.79
- KURA $23.48
- Technical
- Relative Strength Index (RSI)
- HLF 62.25
- KURA 34.40
- Support Level
- HLF $8.16
- KURA $6.95
- Resistance Level
- HLF $8.85
- KURA $8.04
- Average True Range (ATR)
- HLF 0.45
- KURA 0.40
- MACD
- HLF -0.01
- KURA -0.08
- Stochastic Oscillator
- HLF 92.64
- KURA 14.12
About HLF Herbalife Ltd.
Herbalife Ltd is an international nutrition company that provides health and wellness products to consumers in 95 markets, which consist of countries and territories, through their direct-selling business model. Companies' products are weight management; targeted nutrition; Energy, Sports, and Fitness; Outer Nutrition and Literature, Promotional, and Other. Weight management generates the majority of revenue from products like Meal replacements, protein shakes, drink mixes, weight loss enhancers, and healthy snacks. Geographically, the main segments are North America, Mexico, South and Central America, EMEA, Asia-Pacific, and China.
About KURA Kura Oncology Inc.
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.